Tuesday, July 25, 2023

Biogen Q2 Results Top Estimates; Backs FY23 Outlook

Biotechnology company Biogen, Inc. (BIIB) reported Tuesday that net income attributable to the company for the second quarter plunged to $591.6 million or $4.07 per share from $1.06 billion or $7.24 per share in the prior-year quarter.

from RTT - Earnings https://ift.tt/UKTn3AS
via IFTTT

No comments:

Post a Comment